A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|September 4, 2009
Walgreens releases specialty pharmacy report
Author(s)Alaina Scott, Senior Editor
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.
Advertisement
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report, which offers a snapshot of the specialty pharmacy market's evolving trends, as well as solutions for managing costs and improving care.
The report is available online at
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
4
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
5